Report of the Commission on Drug Safety:
Gespeichert in:
| Körperschaft: | |
|---|---|
| Format: | Buch |
| Sprache: | English |
| Veröffentlicht: |
Washington
1964
|
| Schlagworte: | |
| Beschreibung: | IX, 228 S. |
Internformat
MARC
| LEADER | 00000nam a2200000 c 4500 | ||
|---|---|---|---|
| 001 | BV012409833 | ||
| 003 | DE-604 | ||
| 005 | 19990216 | ||
| 007 | t | ||
| 008 | 990216s1964 |||| 00||| eng d | ||
| 035 | |a (OCoLC)831417 | ||
| 035 | |a (DE-599)BVBBV012409833 | ||
| 040 | |a DE-604 |b ger |e rakddb | ||
| 041 | 0 | |a eng | |
| 049 | |a DE-20 | ||
| 110 | 2 | |a Commission on Drug Safety |e Verfasser |0 (DE-588)5277173-8 |4 aut | |
| 245 | 1 | 0 | |a Report of the Commission on Drug Safety |
| 264 | 1 | |a Washington |c 1964 | |
| 300 | |a IX, 228 S. | ||
| 336 | |b txt |2 rdacontent | ||
| 337 | |b n |2 rdamedia | ||
| 338 | |b nc |2 rdacarrier | ||
| 650 | 4 | |a Drug Industry | |
| 650 | 4 | |a Ethics, Pharmacy | |
| 650 | 4 | |a Pharmaceutical Preparations |x adverse effects | |
| 999 | |a oai:aleph.bib-bvb.de:BVB01-008418899 | ||
Datensatz im Suchindex
| _version_ | 1804127044326391808 |
|---|---|
| any_adam_object | |
| author_corporate | Commission on Drug Safety |
| author_corporate_role | aut |
| author_facet | Commission on Drug Safety |
| author_sort | Commission on Drug Safety |
| building | Verbundindex |
| bvnumber | BV012409833 |
| ctrlnum | (OCoLC)831417 (DE-599)BVBBV012409833 |
| format | Book |
| fullrecord | <?xml version="1.0" encoding="UTF-8"?><collection xmlns="http://www.loc.gov/MARC21/slim"><record><leader>00773nam a2200277 c 4500</leader><controlfield tag="001">BV012409833</controlfield><controlfield tag="003">DE-604</controlfield><controlfield tag="005">19990216 </controlfield><controlfield tag="007">t</controlfield><controlfield tag="008">990216s1964 |||| 00||| eng d</controlfield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(OCoLC)831417</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(DE-599)BVBBV012409833</subfield></datafield><datafield tag="040" ind1=" " ind2=" "><subfield code="a">DE-604</subfield><subfield code="b">ger</subfield><subfield code="e">rakddb</subfield></datafield><datafield tag="041" ind1="0" ind2=" "><subfield code="a">eng</subfield></datafield><datafield tag="049" ind1=" " ind2=" "><subfield code="a">DE-20</subfield></datafield><datafield tag="110" ind1="2" ind2=" "><subfield code="a">Commission on Drug Safety</subfield><subfield code="e">Verfasser</subfield><subfield code="0">(DE-588)5277173-8</subfield><subfield code="4">aut</subfield></datafield><datafield tag="245" ind1="1" ind2="0"><subfield code="a">Report of the Commission on Drug Safety</subfield></datafield><datafield tag="264" ind1=" " ind2="1"><subfield code="a">Washington</subfield><subfield code="c">1964</subfield></datafield><datafield tag="300" ind1=" " ind2=" "><subfield code="a">IX, 228 S.</subfield></datafield><datafield tag="336" ind1=" " ind2=" "><subfield code="b">txt</subfield><subfield code="2">rdacontent</subfield></datafield><datafield tag="337" ind1=" " ind2=" "><subfield code="b">n</subfield><subfield code="2">rdamedia</subfield></datafield><datafield tag="338" ind1=" " ind2=" "><subfield code="b">nc</subfield><subfield code="2">rdacarrier</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Drug Industry</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Ethics, Pharmacy</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Pharmaceutical Preparations</subfield><subfield code="x">adverse effects</subfield></datafield><datafield tag="999" ind1=" " ind2=" "><subfield code="a">oai:aleph.bib-bvb.de:BVB01-008418899</subfield></datafield></record></collection> |
| id | DE-604.BV012409833 |
| illustrated | Not Illustrated |
| indexdate | 2024-07-09T18:27:05Z |
| institution | BVB |
| institution_GND | (DE-588)5277173-8 |
| language | English |
| oai_aleph_id | oai:aleph.bib-bvb.de:BVB01-008418899 |
| oclc_num | 831417 |
| open_access_boolean | |
| owner | DE-20 |
| owner_facet | DE-20 |
| physical | IX, 228 S. |
| publishDate | 1964 |
| publishDateSearch | 1964 |
| publishDateSort | 1964 |
| record_format | marc |
| spelling | Commission on Drug Safety Verfasser (DE-588)5277173-8 aut Report of the Commission on Drug Safety Washington 1964 IX, 228 S. txt rdacontent n rdamedia nc rdacarrier Drug Industry Ethics, Pharmacy Pharmaceutical Preparations adverse effects |
| spellingShingle | Report of the Commission on Drug Safety Drug Industry Ethics, Pharmacy Pharmaceutical Preparations adverse effects |
| title | Report of the Commission on Drug Safety |
| title_auth | Report of the Commission on Drug Safety |
| title_exact_search | Report of the Commission on Drug Safety |
| title_full | Report of the Commission on Drug Safety |
| title_fullStr | Report of the Commission on Drug Safety |
| title_full_unstemmed | Report of the Commission on Drug Safety |
| title_short | Report of the Commission on Drug Safety |
| title_sort | report of the commission on drug safety |
| topic | Drug Industry Ethics, Pharmacy Pharmaceutical Preparations adverse effects |
| topic_facet | Drug Industry Ethics, Pharmacy Pharmaceutical Preparations adverse effects |
| work_keys_str_mv | AT commissionondrugsafety reportofthecommissionondrugsafety |